文献速递肝病

肠道糖异生预防肥胖相关肝脂肪变及非酒精性脂肪性肝病

Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease.
PubMed 文献 · Gut · 2020-03-23

该研究利用转基因小鼠模型,分别敲低或过表达肠道葡萄糖-6-磷酸酶以改变肠道糖异生(IGN),发现IGN过表达可保护小鼠在高热量饮食下免于肝脂肪变及NAFLD发生,而IGN抑制则自发加重肝甘油三酯储存。结论提示IGN本身具有预防肝脂肪变及其向NAFLD演进的能力。

要点

  • IGN过表达可抵抗高热量饮食诱导的肝脂肪变和NAFLD启动。
  • 保护作用与减少新生脂肪生成和脂质输入、改善炎症和纤维化相关,并依赖自主神经系统。
  • IGN抑制在标准富淀粉饮食下自发增加肝甘油三酯储存并激活脂肪生成通路。

核心结论

  • 肠道糖异生本身具有预防肝脂肪变及其最终向NAFLD演进的能力。

研究设计与样本

  • 使用两种转基因小鼠品系:一种在肠道特异性敲低葡萄糖-6-磷酸酶,另一种在肠道特异性过表达该酶。

主要发现

  • IGN过表达小鼠在高热量饮食下显著免于肝脂肪变发生和NAFLD启动。
  • 该保护作用与新生脂肪生成和脂质输入减少相关,并伴有炎症和纤维化层面的获益,且与自主神经系统相关。
  • IGN抑制小鼠在标准富淀粉饮食下自发出现肝甘油三酯储存增加,并伴有脂肪生成通路激活。
  • 通过门静脉葡萄糖输注模拟IGN可纠正IGN抑制小鼠的上述表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Hepatic steatosis accompanying obesity is a major health concern, since it may initiate non-alcoholic fatty liver disease (NAFLD) and associated complications like cirrhosis or cancer. Intestinal gluconeogenesis (IGN) is a recently described function that contributes to the metabolic benefits of specific macronutrients as protein or soluble fibre, via the initiation of a gut-brain nervous signal triggering brain-dependent regulations of peripheral metabolism. Here, we investigate the effects of IGN on liver metabolism, independently of its induction by the aforementioned macronutrients. DESIGN: To study the specific effects of IGN on hepatic metabolism, we used two transgenic mouse lines: one is knocked down for and the other overexpresses glucose-6-phosphatase, the key enzyme of endogenous glucose production, specifically in the intestine. RESULTS: We report that mice with a genetic overexpression of IGN are notably protected from the development of hepatic steatosis and the initiation of NAFLD on a hypercaloric diet. The protection relates to a diminution of de novo lipogenesis and lipid import, associated with benefits at the level of inflammation and fibrosis and linked to autonomous nervous system. Conversely, mice with genetic suppression of IGN spontaneously exhibit increased hepatic triglyceride storage associated with activated lipogenesis pathway, in the context of standard starch-enriched diet. The latter is corrected by portal glucose infusion mimicking IGN. CONCLUSION: We conclude that IGN per se has the capacity of preventing hepatic steatosis and its eventual evolution toward NAFLD.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Vily-Petit J, Soty-Roca M, Silva M, et al. Intestinal gluconeogenesis prevents obesity-linked liver steatosis and non-alcoholic fatty liver disease. Gut. 2020. PMID: 32205419. doi:10.1136/gutjnl-2019-319745

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。